Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Amazon
AMZN
|
+$1.13B |
| 2 |
Tesla
TSLA
|
+$1.11B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.04B |
| 4 |
Microsoft
MSFT
|
+$1.03B |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$665M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
+$8.98B |
| 2 |
Technology Select Sector SPDR Fund
XLK
|
+$667M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$510M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$297M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$259M |
Sector Composition
| 1 | Technology | 22.71% |
| 2 | Financials | 14.26% |
| 3 | Communication Services | 11.44% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Healthcare | 10.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILK
2376
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $763K | ﹤0.01% |
13,866
+3,571
| +35% | +$197K |
|
|
TPC
2377
Tutor Perini Corporation
TPC
$3.37B
| $762K | ﹤0.01% |
58,726
+52,364
| +823% | +$679K |
|
2378
Iovance Biotherapeutics
IOVA
$821M
| $761K | ﹤0.01% |
30,890
-59,373
| -66% | -$1.46M |
|
2379
Surmodics
SRDX
$457M
| $760K | ﹤0.01% |
13,678
+6,160
| +82% | +$342K |
|
|
NTUS
2380
DELISTED
Natus Medical Inc
NTUS
| $760K | ﹤0.01% |
30,285
+7,538
| +33% | +$189K |
|
2381
OraSure Technologies
OSUR
$242M
| $759K | ﹤0.01% |
67,126
+19,926
| +42% | +$225K |
|
2382
Banco Bilbao Vizcaya Argentaria
BBVA
$110B
| $758K | ﹤0.01% |
114,956
-30,907
| -21% | -$204K |
|
2383
Ocular Therapeutix
OCUL
$2.23B
| $757K | ﹤0.01% |
75,737
+59,369
| +363% | +$593K |
|
2384
Gabelli Equity Trust
GAB
$1.94B
| $756K | ﹤0.01% |
121,173
-178,587
| -60% | -$1.11M |
|
2385
Quince Therapeutics
QNCX
$85.9M
| $756K | ﹤0.01% |
8,253
+5,551
| +205% | +$508K |
|
2386
iShares 1-3 Year International Treasury Bond ETF
IGOV
$1.12B
| $754K | ﹤0.01% |
14,674
+2,422
| +20% | +$124K |
|
2387
Santander
BSBR
$40.1B
| $752K | ﹤0.01% |
119,937
+104,127
| +659% | +$653K |
|
2388
Byline Bancorp
BY
$1.33B
| $752K | ﹤0.01% |
30,620
+9,780
| +47% | +$240K |
|
2389
Adtran
ADTN
$809M
| $750K | ﹤0.01% |
39,991
+13,327
| +50% | +$250K |
|
|
RAD
2390
DELISTED
Rite Aid Corporation
RAD
| $746K | ﹤0.01% |
52,571
+982
| +2% | +$13.9K |
|
2391
DMC Global
BOOM
$145M
| $745K | ﹤0.01% |
20,181
+10,115
| +100% | +$373K |
|
2392
iShares MSCI Singapore ETF
EWS
$818M
| $745K | ﹤0.01% |
+32,729
| New | +$745K |
|
|
HFRO
2393
Highland Opportunities and Income Fund
HFRO
$360M
| $745K | ﹤0.01% |
53,624
+8,275
| +18% | +$115K |
|
2394
Vanguard Mid-Cap Growth ETF
VOT
$17.8B
| $745K | ﹤0.01% |
3,157
-1,474
| -32% | -$348K |
|
|
EGIO
2395
DELISTED
Edgio, Inc. Common Stock
EGIO
| $744K | ﹤0.01% |
7,821
+866
| +12% | +$82.4K |
|
2396
Assembly Biosciences
ASMB
$173M
| $742K | ﹤0.01% |
17,748
+4,235
| +31% | +$177K |
|
2397
Microvision
MVIS
$343M
| $742K | ﹤0.01% |
67,176
+36,357
| +118% | +$402K |
|
2398
Invesco S&P 500 Equal Weight ETF
RSP
$74.7B
| $742K | ﹤0.01% |
4,950
-628
| -11% | -$94.1K |
|
|
SY
2399
So-Young International
SY
$374M
| $742K | ﹤0.01% |
174,217
+50,087
| +40% | +$213K |
|
2400
John B. Sanfilippo & Son
JBSS
$737M
| $740K | ﹤0.01% |
9,046
+2,846
| +46% | +$233K |
|